S

Simply Better Brands Corp
XTSX:SBBC

Watchlist Manager
Simply Better Brands Corp
XTSX:SBBC
Watchlist
Price: 1.02 CAD 0.99%
Market Cap: 96m CAD
Have any thoughts about
Simply Better Brands Corp?
Write Note

Relative Value

SBBC doesn't have a meaningful market cap.

The Relative Value of one SBBC stock under the Base Case scenario is 0.5 CAD. Compared to the current market price of 1.02 CAD, Simply Better Brands Corp is Overvalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SBBC Relative Value
Base Case
0.5 CAD
Overvaluation 51%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
23
vs Industry
78
Median 3Y
0.3
Median 5Y
0.3
Industry
2.5
Forward
1.3
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1.8
Industry
21.8
Forward
-33.9
vs History
vs Industry
19
Median 3Y
-6.4
Median 5Y
-6.5
Industry
16.1
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-3.4
Industry
23.8
vs History
10
vs Industry
43
Median 3Y
0.7
Median 5Y
0.6
Industry
2.1
vs History
23
vs Industry
75
Median 3Y
0.4
Median 5Y
0.4
Industry
2.7
Forward
1.3
vs History
23
vs Industry
75
Median 3Y
0.8
Median 5Y
0.8
Industry
5.2
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-6.2
Industry
13.5
Forward
25.5
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-4.4
Industry
16.8
vs History
vs Industry
16
Median 3Y
-9.6
Median 5Y
-9.8
Industry
15.2
vs History
vs Industry
16
Median 3Y
-8.9
Median 5Y
-9
Industry
19.3
vs History
19
vs Industry
6
Median 3Y
2.5
Median 5Y
3.4
Industry
1.9

Multiples Across Competitors

SBBC Competitors Multiples
Simply Better Brands Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Simply Better Brands Corp
XTSX:SBBC
93.8m CAD 1.4 -7.7 -41.8 -18.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
750.9B USD 18.4 89.8 48.2 53.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.8T DKK 10.3 29.6 20.5 23.5
US
Johnson & Johnson
NYSE:JNJ
346.5B USD 4 23.6 11.4 14.9
US
Merck & Co Inc
NYSE:MRK
250.3B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
199.5B CHF 3.4 17.3 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.2B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.3B CHF 3.8 10.9 9.4 13.2
US
Pfizer Inc
NYSE:PFE
149.9B USD 2.5 35.3 10.5 15.9
P/S Multiple
Revenue Growth P/S to Growth
CA
S
Simply Better Brands Corp
XTSX:SBBC
Average P/S: 382 942.1
1.4
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
4 211 733
22%
194 879.4
US
Eli Lilly and Co
NYSE:LLY
18.4
109%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
578.3
29%
19.9
DK
Novo Nordisk A/S
CSE:NOVO B
10.3
77%
0.1
US
Johnson & Johnson
NYSE:JNJ
4
13%
0.3
US
Merck & Co Inc
NYSE:MRK
4
20%
0.2
CH
Roche Holding AG
SIX:ROG
3.4
15%
0.2
UK
AstraZeneca PLC
LSE:AZN
4.1
35%
0.1
CH
Novartis AG
SIX:NOVN
3.8
17%
0.2
US
Pfizer Inc
NYSE:PFE
2.5
10%
0.3
P/E Multiple
Earnings Growth P/E to Growth
CA
S
Simply Better Brands Corp
XTSX:SBBC
Average P/E: 32.3
Negative Multiple: -7.7
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.8
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29.6
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.6
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.6
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.3
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.9
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.3
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
S
Simply Better Brands Corp
XTSX:SBBC
Average EV/EBITDA: 459.6
Negative Multiple: -41.8
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.2
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.5
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.4
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.4
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
S
Simply Better Brands Corp
XTSX:SBBC
Average EV/EBIT: 2 011.3
Negative Multiple: -18.2
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.8
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23.5
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.2
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top